000 01328 a2200349 4500
005 20250516120410.0
264 0 _c20130612
008 201306s 0 0 eng d
022 _a1744-8336
024 7 _a10.1586/eri.12.114
_2doi
040 _aNLM
_beng
_cNLM
100 1 _avan Lelyveld, Steven F L
245 0 0 _aThe MOTIVATE trials: maraviroc therapy in antiretroviral treatment-experienced HIV-1-infected patients.
_h[electronic resource]
260 _bExpert review of anti-infective therapy
_cNov 2012
300 _a1241-7 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aAnti-Retroviral Agents
_xadverse effects
650 0 4 _aCCR5 Receptor Antagonists
650 0 4 _aCyclohexanes
_xadverse effects
650 0 4 _aDrug Therapy, Combination
650 0 4 _aHIV Infections
_xdrug therapy
650 0 4 _aHIV-1
_xphysiology
650 0 4 _aHumans
650 0 4 _aMaraviroc
650 0 4 _aRandomized Controlled Trials as Topic
650 0 4 _aTriazoles
_xadverse effects
650 0 4 _aViral Tropism
700 1 _aWensing, Annemarie M J
700 1 _aHoepelman, Andy I M
773 0 _tExpert review of anti-infective therapy
_gvol. 10
_gno. 11
_gp. 1241-7
856 4 0 _uhttps://doi.org/10.1586/eri.12.114
_zAvailable from publisher's website
999 _c22227364
_d22227364